Disclosure about Fair Value of Financial Instruments (Details 1) - USD ($) $ in Thousands		Sep. 30, 2016		Dec. 31, 2015
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Available-for-sale equity investments		$ 17,527	[1]	$ 22,779
Foreign currency forward contracts	[2]	129,839
Redeemable OP unitholder interests		123,446
Totals		270,812
Level 1 [Member]
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Available-for-sale equity investments	[1]	17,527
Totals		17,527
Level 2 [Member]
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Foreign currency forward contracts	[2]	129,839
Redeemable OP unitholder interests		123,446
Totals		$ 253,285

[1] (1) Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date. During the year ended December 31, 2015, we recognized an other than temporary impairment charge of $35,648,000 on the Genesis Healthcare stock investment. Also, see Note 11 for details related to the gain on the derivative asset originally recognized.

[2] (2) Please see Note 11 for additional information.